These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15964389)

  • 1. Donor CCR5 Delta32 polymorphism and outcome following cardiac transplantation.
    Fildes JE; Walker AH; Howlett R; Bittar MN; Hutchinson IV; Leonard CT; Yonan N
    Transplant Proc; 2005 Jun; 37(5):2247-9. PubMed ID: 15964389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation.
    Hummel M; Bara C; Hirt S; Haverich A; Hetzer R
    Transpl Immunol; 2007 Apr; 17(3):223-6. PubMed ID: 17331851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chemokine receptor CCR2 and CCR5 gene polymorphism on allograft outcome in North Indian renal transplant recipients.
    Singh R; Kapoor R; Srivastava A; Mittal RD
    Scand J Immunol; 2009 Jan; 69(1):51-6. PubMed ID: 19037908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5.
    Cha RH; Yang SH; Kim HS; Kim SM; Park MH; Ha J; Kim YS
    Nephrol Dial Transplant; 2009 Sep; 24(9):2919-25. PubMed ID: 19561149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chemokine receptor gene polymorphisms (CCR2V64I, CCR5-59029G>A and CCR5Δ32) on renal allograft survival in Pakistani transplant patients.
    Firasat S; Raza A; Abid A; Aziz T; Mubarak M; Naqvi SA; Rizvi SA; Mehdi SQ; Khaliq S
    Gene; 2012 Dec; 511(2):314-9. PubMed ID: 23041556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation.
    Moench C; Uhrig A; Lohse AW; Otto G
    Liver Transpl; 2004 Mar; 10(3):434-9. PubMed ID: 15004773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 deletion mutation and its association with the risk of developing acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Bogunia-Kubik K; Duda D; Suchnicki K; Lange A
    Haematologica; 2006 Dec; 91(12):1628-34. PubMed ID: 17145599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CC chemokine receptor 5 and 2 polymorphisms and renal transplant survival.
    Yigit B; Bozkurt N; Berber I; Titiz I; Isbir T
    Cell Biochem Funct; 2007; 25(4):423-6. PubMed ID: 16598837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CCR5-59029 A/G and CCR2-V64I variants with renal allograft survival.
    Omrani MD; Mokhtari MR; Tagizadae A; Bagheri M; Ahmad-Poor P
    Iran J Immunol; 2008 Dec; 5(4):201-6. PubMed ID: 19098363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor 2-V64I and chemokine receptor 5-Delta32 polymorphisms and clinical risk factors of delayed graft function and acute rejection in kidney transplantation.
    Azmandian J; Mandegary A; Saber A; Torshabi M; Etminan A; Ebadzadeh MR; Fazeli F; Soleymani S; Taghipour A; Karimi MA
    Iran J Kidney Dis; 2012 Jan; 6(1):56-62. PubMed ID: 22218121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
    Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
    J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of functional CCR5 and EBV reactivation after allogeneic haematopoietic stem cell transplantation.
    Bogunia-Kubik K; Jaskula E; Lange A
    Bone Marrow Transplant; 2007 Jul; 40(2):145-50. PubMed ID: 17530006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism of CC chemokine ligand 5 promoter gene in recipients may predict the risk of chronic graft-versus-host disease and its severity after allogeneic transplantation.
    Kim DH; Jung HD; Lee NY; Sohn SK
    Transplantation; 2007 Oct; 84(7):917-25. PubMed ID: 17984846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphism of chemokine receptors CCR2 and CCR5 in Swedish cervical cancer patients.
    Zheng B; Wiklund F; Gharizadeh B; Sadat M; Gambelunghe G; Hallmans G; Dillner J; Wallin KL; Ghaderi M
    Anticancer Res; 2006; 26(5B):3669-74. PubMed ID: 17094383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.